Predictive value of TyG-BMI, CTI, and SII in identifying metabolic dysfunction-associated steatotic liver disease among patients with type 2 diabetes mellitus (opens in new tab)

BackgroundMetabolic dysfunction–associated steatotic liver disease (MASLD) has become a major comorbidity in patients with type 2 diabetes mellitus (T2DM). This study aimed to evaluate the diagnostic performance of the triglyceride-glucose–body mass index (TyG-BMI), the C-reactive protein–triglyceride–glucose index (CTI), and the systemic immune-inflammation index (SII), individually and in combination, for identifying MASLD in patients with T2DM.MethodsThis retrospective cross-sectional stud...